30th ADLM International CPOCT Symposium

DoubleTree Pittsburgh | October 14–16, 2026

  • Start Date
    Oct 14, 2026
  • End Date
    Oct 16, 2026
  • Location
    Pittsburgh, PA
  • CE Credits
    Up to 12.0 ACCENT
  • Duration
    3 days
  • Price
    $750
  • Member Price
    $500
Register
CPOCT attendees at a registration booth

Poster abstracts

The planning committee for the 2026 ADLM International CPOCT Symposium thanks you for your poster abstract submissions. Authors of accepted abstracts will be invited to display their poster(s) during the conference and must register to do so.

View accepted abstracts here.

Key details and dates

  • The deadline for abstract submission was August 28, 2026.
  • Acceptance notices will be sent by September 4.
  • Authors of accepted abstracts must confirm participation and register by September 14. Please note that authors will need to present their posters at the conference in person to be included in the abstract publication.
  • Submitters of the top poster abstract submissions will be invited to present their work as a 15-minute oral presentation to an audience of thought-leaders and peers in addition to displaying their poster(s) during the conference.
  • Presented poster abstracts will be published as a supplement issue in ADLM's online peer-reviewed publication, The Journal of Applied Laboratory Medicine (JALM).

Registration

Presenting authors are required to register as conference attendees and present their posters in person. Any requests to change the presenting author must be made in writing to [email protected] by September 14 for consideration. Poster abstracts will not be included in program materials or JALM supplement until registration and attendance of the presenting author is confirmed.

Withdrawal

If you plan to withdraw your abstract, please notify [email protected] in writing as soon as possible including the abstract title and author name.

Publication and presentation

All accepted posters will be published as a supplement in the ADLM's online peer-reviewed publication, The Journal of Applied Laboratory Medicine (JALM). Additional details on poster preparation will be provided after notices are sent September.

Poster preparation guidelines & requirements

Poster size and display board

ADLM does not provide poster printing services. It is the responsibility of poster presenters to prepare and print their poster(s) for display on the provided poster boards. Please review the size and space information carefully as you prepare your poster. 

  • The maximum size for an accepted poster is 46 inches (117 cm) x 46 inches (117 cm). If your poster exceeds the limit, it may be cut, folded, or otherwise modified to permit the allotted display room.
  • The poster abstract number provided by ADLM will be placed in the upper corner and measures 8.5 inches wide by 5.5 inches high (approximately 22 cm x 14 cm).

Required poster information

Each accepted poster must contain the following information:

  • Title as submitted in your abstract submission.
  • Presenting author and all co-authors.
  • Author(s) affiliation(s).
  • Background of your study (why you did this work).
  • Method(s) used to achieve a solution.
  • Results obtained (figures, tables, etc.).
  • Conclusions and importance of your work to laboratory medicine.

Please note that ADLM only provides the poster abstract number placed in the upper corner. It is the responsibility of the poster presenter to print and display their poster(s) at the designated times.

General poster guidance

  • The information you display should have a professional appearance.
  • All information should be easily read from at least 5 feet away from your poster.
  • Headings for abstract title and numbering for subsections should be a minimum of 72 pt font (approximately 1 inch or 2.5 cm height).
  • Subheadings should be a minimum of 36 pt font (approximately 0.5 inches or 1 cm height).
  • All type should be a minimum of 24 pt font (approximately 0.3 inches or 0.8 cm height) and readable from a distance of 5-7 feet (1.5-1.7 meters).

Restrictions

  • Instruments, components, or reagents are NOT permitted in the poster area.

Poster session schedule

You are required to set up your poster between 5 – 6 pm on Wednesday, October 14, 2026. Please collect your badge at the registration table and identify your poster number for your spot in the poster presentation section.

Your poster is to remain on display for the entire duration of the conference and removed by Friday, October 16, 2026 by 4:30 pm.

ADLM is not responsible for posters left on boards after the conference concludes.

List of accepted scientific poster abstracts

Accepted posters are listed in alphabetical order, by last name. Poster numbers will be assigned before the conference. Poster presentations will be on display starting Wednesday, October 14 at 6:00 pm. Poster displays conclude at the end of the conference on Friday, October 16 at 4:30 pm.

  • Development and Characterization of Human Plasma-Based Internal Quality Control Materials for HIV Point-of-Care Testing
    Napaporn Apiratmateekul, Phitsanulok, Thailand
  • HELIX-LAMP: A Portable Isothermal Nucleic Acid Amplification Platform for Rapid Field Diagnostics
    Ayesha Azimuddin, Philadelphia, PA, United States
  • Assessing the Effects of Interfering Substances on Whole Blood Clotting Time Measured by a DOAC-Sensitive Point-of Care Coagulometer
    Sasha Bakhru, Danbury, CT, United States
  • Closing the Loop at the Primary Care Unit: Integrating Point-of-Care Testing, Multi-Frequency Vibrometry, Continuous Glucose Monitoring, and Device-Assisted Neurorehabilitation into Thailand's Nationwide POCT-Telehealth Network
    Arirat Banpavichit, Bangkok, Thailand
  • Pilot Study of SOFIA POCT Rapid Lyme Disease Test in Pediatric Emergency Settings Compared to Routine LIASON Workflow
    Magdalena Baumgartner, Morgantown, WV, United States
  • Fast, sensitive, and culture-independent: Molecular point-of-care detection of Group A Streptococcus
    Sydney Bennett, Austin, TX, United States
  • Systematic Comparison of Electrolyte Measurements in POCT versus Central Laboratory Analyzers: Implications for Critical Decisions in ICU
    Jayeeta Bhadra, North Delhi, Delhi, India
  • Testing Smarter: Cost savings from a rapid, risk-stratified Syndromic Respiratory solution (BIOFIRE® SPOTFIRE® R/ST Panel) in high-risk urgent care patients
    Federico Cairoli, Marcy-L'etoile, France
  • Point-of-care viscoelastic testing reduces length of stay and blood product utilization in cardiac surgery patients
    Sean Carey, Browns Mills, NJ, United States
  • From Complexity to Compliance: Leveraging Technology for Competency Management in a Large POCT Network
    Leh Chang, Loma Linda, CA, United States
  • Reducing Documentation Errors in Point of care Testing: A practical PDCA-Based Approach to Improve Compliance in Clinical Settings
    Scarlin Chavarria, Miami, FL, United States
  • Use of a Binary Clinical Decision-Making Process to Reconcile Medical Decision Point Method Differences in Activated Clotting Time Tests to Assist in Method Crossover Interpretation
    Alex Chin, Boston, MA, United States
  • TriVerity rapid host response testing in adult emergency department patients with suspected acute infection: an interventional study
    Gaby Dashler, Baltimore, MD, United States
  • High User Satisfaction and Workflow Improvement Following Implementation of Molecular Point-of-Care Testing in the Emergency Department
    Kim Evans, Mobile, AL, United States
  • From Planning to Go-Live: Practical Takeaways from Migrating to a New Point-of-Care (POC) Middleware Connectivity
    Malerie Goh, Singapore, Singapore
  • Integrating a Real-Time Data Management Point-of-Care (POC) Connectivity Solution into Hospital Diabetes Outpatient Clinic POC Testing Workflow
    Malerie Goh, Singapore, Singapore
  • High Burden of Positive Cannabinoid Screens in a Pediatric Emergency Department Supports the Need for Point-of-Care Testing
    Sarah Grubb, Pittsburgh, PA, United States
  • Implementation of New POC Analyzers: Importance of Postimplementation Follow-up
    Monica Ianosi-Irimie, Camden, NJ, United States
  • Beyond the “Meter Disinfected” Button: A Proactive Quarterly Audit Approach to Glucometer Disinfection For Patient Safety
    Nichole Korpi-Steiner, Chapel Hill, NC, United States
  • A multisite analysis of waste generation from 100,000 blood gas analysis tests
    Nicholas Larkey, Charlottesville, VA, United States
  • Transforming Ambulatory Point-of-Care Testing Through Network-Wide Standardization
    Lana Lyle, Pittsburgh, PA, United States
  • Comparative assessment of PCR-based and rapid antigen testing for group A Streptococcus in an integrated health system
    Kelsey Lyons, Pittsburgh, PA, United States
  • Beyond the Lab: Usability of an FDA-Cleared Host-Response Point-of-Care Device Among Non-Laboratory Certified Personnel
    Breana McBryde, Baltimore, MD, United States
  • Evaluation of a Whole Blood Point-of-Care Test for Traumatic Brain Injury in the Emergency Care Setting
    Joshua Pantanowitz, Pittsburgh, PA, United States
  • Generative artificial intelligence use, comfort, and implementation priorities among point-of-care testing professionals: an international survey
    Joshua Pantanowitz, Pittsburgh, PA, United States
  • Cost-Analysis for Transportable versus Handheld Point-of-Care Whole Blood Analysis
    Brina Ratangee, Pittsburgh, PA, United States
  • Impact of Rapid Point-of-Care Molecular Testing on Antimicrobial Stewardship in a Tertiary-Care Hospital in Peshawar, Pakistan
    Mujeeb Rehman, Peshawar, Pakistan
  • Characterization of Upper Arm Capillary Blood Collection Performance: Effects of Pre-Warming, Collection Site, and Collection Order
    Michelle Seaton, Brampton, ON, Canada
  • A Validated Smartphone-Based Platform for application in Quantitative Point-of-Care and At-home Testing of Total Cholesterol and Triglycerides in a colorimetric  paper-microfluidic assay
    Prava Sharma, Philadelphia, PA, United States
  • Extrinsic clot time concordance between Quantra® QPlus® and ROTEM® delta in the cardiopulmonary context
    Nat Sherwood, Durham, NC, United States
  • An Evaluation of Factors Influencing i-STAT Device Lifespan
    Tiffany Stenzel, Saint Paul, MN, United States
  • A handheld plasma separator suitable for multimodal blood tests in remote settings
    Meng Sun, Durham, NC, United States
  • To Transfuse or Not to Transfuse: Are Point-of-Care Haemoglobin Results Fit for Transfusion Decision-Making?
    Carol Hui Chen Tan, Singapore, Singapore
  • Evaluation of CSAN PRONTO devices for measuring absolute neutrophil count in patients taking Clozapine: A study from Newfoundland and Labrador, Canada
    Vinita Thakur, St John's, NL, Canada
  • Toward AI-enabled differentiation of dengue and influenza using routine CBC data for point-of-care decision support
    Kittisak Thawnashom, Phitsanulok, Thailand
  • Creatinine Discordance Prior to Contrast-Enhanced CT: Implications of Point-of-Care Versus Central Laboratory Testing
    Melissa Ulas, Philadelphia, PA, United States
  • Complexity behind the waiver: real-world perspectives and framework for successful implementation of emerging point-of-care technologies from a large healthcare network
    Jesse Young, Albuquerque, NM, United States
  • Evaluation of Hemolysis Rates at a Tertiary Care Institution Across Adult and Neonatal Blood Gas Specimens
    Nick Zaia, Bedford, MA, United States
  • Feasibility of a Recent FDA-Cleared, CLIA-Waived Point-of-Care Hepatitis C Virus RNA Test in a U.S. Urban Emergency Department
    Kevin Zhang, Baltimore, MD, United States

Questions?

Email [email protected].